Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs

Published: Sunday, March 03, 2013
Last Updated: Saturday, March 02, 2013
Bookmark and Share
Sapio Solutions' Exemplar LIMS selected by NY Genome Center's laboratory operations.

Exemplar LIMS™ has been selected as the primary lab management and electronic lab notebook (ELN) solution for NY Genome Center's laboratory operations.  Sapio's LIMS system will initially track next generation sequencing workflows from the Illumina family of sequencers from request through analysis.   Support for additional next gen sequencers will be added as needed.

Sapio's LIMS software will be deployed on Apple iPads™ using Exemplar LIMS for Tablets solution.  This enables lab technicians to take the LIMS with them as they move around the laboratory, improving LIMS usability and lab technician efficiency.    NY Genome Center will also be utilizing Exemplar's Materials Management capabilities for detailed tracking of reagent usage.  NYGC will ultimately be processing samples for both research and clinical applications via a CLIA certified laboratory.  Sapio's experience with implementing best practices for both research and clinical labs will accelerate the LIMS implementation in support of these NYGC objectives.

"The team at New York Genome Center has been impressed with the flexibility and scalability of Sapio's offerings," commented NYGC President & Scientific Director Robert B. Darnell, MD, PhD. "With Sapio we found an entrepreneurial partner that understands how important customer service and collaboration are to NYGC. We look forward to working with Sapio to design a solution for the genome center of the future."

 "The leadership at NYGC has recognized the importance of next generation sequencing technology for both research and clinical applications and has assembled a top-notch team from top to bottom.  We are both honored and enthused to be supporting the NYGC objectives with the ultimate goal of curing diseases," said Kevin Cramer, VP at Sapio Sciences. "We look forward to working with the NYGC team towards creating a world-class lab operation as they scale to be one of the largest NGS facilities in the North America."


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More Than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Mount Sinai Selects Exemplar LIMS for Genomics Core Facility
Exemplar LIMS utilized for Mount Sinai CLIA-certified Genomics Core Facility employing diverse NGS platforms
Tuesday, May 07, 2013
New York Genome Institute Selects Exemplar LIMS to Manage Next Gen Sequencing Labs
Sapio Sciences' Exemplar LIMS to be utilized for NYGC High Throughput Next Gen Sequencing Labs
Wednesday, February 13, 2013
Sapio Sciences Announces Exemplar LIMS for Tablet Computers
Lab Technicians can now use Exemplar LIMS Untethered.
Wednesday, November 14, 2012
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Blood Pressure Drug May Boost Effectiveness of Lung Cancer Treatment
Researchers at Imperial College London have suggested that the blood pressure drug may make a type of lung cancer treatment more effective.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Uncovering Cancer’s ‘Invisibility Cloak’
Researchers discover cancer cell mechanism to become invisible to the body's immune system.
Genetic Impact of Endurance Training
Research has found that endurance training changes genetic activity in thousands of genes, giving rise to large number of altered RNA variants.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!